Literature DB >> 11476780

A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio.

A M Fulghesu1, M Ciampelli, C Belosi, R Apa, V Pavone, A Lanzone.   

Abstract

OBJECTIVE: To evaluate whether some ultrasound parameters of ovarian morphology can discriminate between control women and patients with polycystic ovary syndrome (PCOS).
DESIGN: Retrospective data analysis.
SETTING: Volunteers women in an academic research environment. PATIENT(S): Eighty amenorrheic or oligomenorrheic women and 30 normal ovulatory control participants. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): We evaluated ovarian volume, area, stroma, and the stroma/total area (S/A) ratio by use of transvaginal pelvic ultrasound; and we assayed serum levels of gonadotropin, androgen, and estradiol during the early follicular phase (days 2 to 5) of the menstrual cycle in regularly cycling controls and on a random day in amenorrheic patients. RESULT(S): Patients with PCOS showed significantly higher ovarian volume, area, stroma, and mean S/A ratio when compared to multifollicular and control groups. Cut-off values have been defined for ovarian volume (13.21 mL), area (7.00 cm2), stroma (1.95 cm2), and S/A ratio (0.34). The sensitivity for PCOS diagnosis was 21%, 4%, 62%, and 100%, respectively. The S/A ratio showed the most significant correlation with the androgen levels. CONCLUSION(S): The evaluation of the S/A ratio can differentiate between PCOS and control or multifollicular women with both a sensitivity and a specificity of 100%. Furthermore, this ultrasound parameter is strictly related to hormonal milieu and to anthropometric characteristics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11476780     DOI: 10.1016/s0015-0282(01)01919-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  19 in total

1.  Grid analysis improves reliability in follicle counts made by ultrasonography in women with polycystic ovary syndrome.

Authors:  Marla E Lujan; Eric D Brooks; Anna L Kepley; Donna R Chizen; Roger A Pierson; Andrew K Peppin
Journal:  Ultrasound Med Biol       Date:  2010-04-09       Impact factor: 2.998

2.  GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.

Authors:  F Orio; S Palomba; A Colao; T Russo; C Dentico; L Tauchmanovà; S Savastano; C Nappi; C Sultan; F Zullo; G Lombardi
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

3.  Insulin and GH secretion in adolescent girls with irregular cycles: polycystic vs multifollicular ovaries.

Authors:  P Villa; A Rossodivita; A M Fulghesu; F Cucinelli; A Barini; R Apa; C Belosi; A Lanzone
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

4.  Predictive value of ovarian stroma measurement for cardiovascular risk in polycyctic ovary syndrome: a case control study.

Authors:  Giuseppe Loverro; Giovanni De Pergola; Edoardo Di Naro; Massimo Tartagni; Cristina Lavopa; Anna Maria Caringella
Journal:  J Ovarian Res       Date:  2010-11-09       Impact factor: 4.234

Review 5.  Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.

Authors:  Marla E Lujan; Donna R Chizen; Roger A Pierson
Journal:  J Obstet Gynaecol Can       Date:  2008-08

6.  Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: a case report.

Authors:  M Guido; D Romualdi; C Belosi; L Selvaggi; A Lanzone
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

7.  Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.

Authors:  S Alsamarai; J M Adams; M K Murphy; M D Post; D L Hayden; J E Hall; C K Welt
Journal:  J Clin Endocrinol Metab       Date:  2009-10-21       Impact factor: 5.958

8.  Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries.

Authors:  Napoleone Ferrara; Gretchen Frantz; Jennifer LeCouter; Lisa Dillard-Telm; Thinh Pham; Aparna Draksharapu; Thomas Giordano; Franklin Peale
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

9.  Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.

Authors:  D Romualdi; S De Cicco; M Busacca; D Gagliano; A Lanzone; M Guido
Journal:  J Endocrinol Invest       Date:  2013-09       Impact factor: 4.256

10.  Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement.

Authors:  Marla E Lujan; Donna R Chizen; Andrew K Peppin; Anita Dhir; Roger A Pierson
Journal:  J Ovarian Res       Date:  2009-06-10       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.